Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
219 participants
INTERVENTIONAL
2011-10-31
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
CVD Risk Reduction Trial
NCT00473785
Randomised Trial of Health Coaching in Secondary Prevention of Diabetes and Heart Disease
NCT00552903
Preventative Screening and Health Coaching in a Food Insecure Population
NCT06907524
Preventing Diabetes in Those at Risk by Having a Facilitator and Family Doctor Encourage Healthy Activity and Eating Habits
NCT01589835
GENErating Behavior Change, An Integrative Health Coaching and Genetic Risk Testing Pilot
NCT01766271
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Health Coaching
Health Coaching
The intervention will take approximately six months to complete. A combination of group and individual face-to-face meetings will be used. Participants will be divided into groups of 20 for group meetings. Groups will be brought together for a group coaching session at the beginning and the end of the coaching process (i.e., intervention). Each participant will also receive four individual coaching sessions with the health coach and will be able to avail of three one-hour telephone coaching sessions during the six month intervention. Participants will be encouraged to utilize telephone coaching for key support periods.
Usual Care -Control
Patients assigned to the control (usual care) group will be advised to seek standard lifestyle counselling from their primary care physician.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Health Coaching
The intervention will take approximately six months to complete. A combination of group and individual face-to-face meetings will be used. Participants will be divided into groups of 20 for group meetings. Groups will be brought together for a group coaching session at the beginning and the end of the coaching process (i.e., intervention). Each participant will also receive four individual coaching sessions with the health coach and will be able to avail of three one-hour telephone coaching sessions during the six month intervention. Participants will be encouraged to utilize telephone coaching for key support periods.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Last recorded fasting blood glucose between 6.0 abd 6.9 mmol/L
* Last recorded blood pressure between 130-139 mmHG systolic and/or85-89 mmHG diastolic
Exclusion Criteria
* Diagnosis of hypertension on the chart
* taking an anti-diabetic medication
* taking an antihypertensive medication
40 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
Marshal Godwin
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marshal Godwin
Professor, Faculty of Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marshall Godwin, MD, MSc
Role: PRINCIPAL_INVESTIGATOR
Memorial University of Newfoundland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Memorial University of Newfoundland
St. John's, Newfoundland and Labrador, Canada
Memorial University of Newfoundland
St. John's, Newfoundland and Labrador, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
243401
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.